23 May 2018 | 7:34 PM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
515.46
3.80
(0.75 %)
23 May 2018 | 03:59 PM
Change company
  • Open (Rs)
    516.00
  • Prev. close (Rs.)
    511.65
  • High (Rs.)
    523.30
  • Low (Rs.)
    510.00
  • 52W H (Rs.)
    720.90
  • 52W L (Rs.)
    494.50
  • Volume
    52154
  • MCap (Rs in Cr.)
    14,544.35
514.75
1.90
(0.37 %)
  • Open (Rs)
    516.85
  • High (Rs)
    523.45
  • Low (Rs)
    511.55
  • Prev. close(Rs)
    512.85
  • Contracts Tra.
    17,99,100
  • Turnover (Cr.)
    93
  • Open Interest
    57,96,900
  • Open Int. chg
    3,60,900.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.30
Operating Margin (%)
22.17
Gross Profit Margin (%)
19.29
Net Profit Margin (%)
12.07
Total Debt/Equity
1.05
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

22 May 2018 - 09:28:00-Glenmark Pharmaceuticals a global pharmaceutical company has said that the company has submitted a N...
21 May 2018 - 09:29:00-Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food ...
18 May 2018 - 09:30:00-Glenmark Pharmaceuticals a global pharmaceutical company has said that it has announced data from a ...
16 May 2018 - 09:35:00-Glenmark Pharmaceuticals has said that it has launched a generic version of Seretide® Accuhaler&...

Announcements

23-May-2018
Glenmark Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
23-May-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22-May-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
22-May-2018
Glenmark Pharma - Press Release
21-May-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Religare Research

23 May 2018 | 12:00 AM
Swaraj Engines Ltd’s (SEL) Q4FY18 numbers were more or less in-line with our estimates with net reve...
22 May 2018 | 11:07 AM
Highlights: • Normal Monsoon and its early arrival predictions by the IMD kept pressure on the...
22 May 2018 | 10:26 AM
DTF
22 May 2018 | 10:15 AM
The rupee ended at 68.12 to a dollar, lowest since Jan. 24, 2017, against 68.01 at the previous clos...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 72.88 0.20
10,00,000 115.06 64.21 0.20
10,00,000 115.06 203.59 0.20
10,00,000 115.06 212.15 0.21
10,00,000 115.06 76.73 0.21

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI3.64%
FI/Banks2.98%
Insurance2.98%
FII30.75%
Government0.00%
Others4.73%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
6,650.00(1.55)
3280
 Sanofi India Ltd.
4,949.00(0.31)
3325
 Pfizer Ltd.
2,419.00(2.56)
3370
 GlaxoSmithKline Pharmaceuticals Ltd.
2,395.00(-0.80)
3317

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.-64.05-8.95-74.95
NIFTY(S&P CNX)-154.3547.6588.05
BSE SENSEX-105.86525.41783.36
BSE 500-468.91-86.17-168.16

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda